The Pathogenic Role of Very Low Density Lipoprotein on Atrial Remodeling in the Metabolic Syndrome
Atrial fibrillation (AF) is the most common persistent arrhythmia, and can lead to systemic thromboembolism and heart failure. Aging and metabolic syndrome (MetS) are major risks for AF. One of the most important manifestations of MetS is dyslipidemia, but its correlation with AF is ambiguous in cli...
Main Authors: | Hsiang-Chun Lee, Yi-Hsiung Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/3/891 |
Similar Items
-
VLDL from Metabolic Syndrome Individuals Enhanced Lipid Accumulation in Atria with Association of Susceptibility to Atrial Fibrillation
by: Hsiang-Chun Lee, et al.
Published: (2016-01-01) -
The role of postprandial very-low-density lipoprotein in the development of atrial remodeling in metabolic syndrome
by: Hsiang-Chun Lee, et al.
Published: (2020-09-01) -
Very Low-Density Lipoproteins of Metabolic Syndrome Modulates STIM1, Suppresses Store-Operated Calcium Entry, and Deranges Myofilament Proteins in Atrial Myocytes
by: Yi-Lin Shiou, et al.
Published: (2019-06-01) -
The Role of Atrial Remodelling in Atrial Fibrillation
by: Ignatius Yansen, et al.
Published: (2013-06-01) -
Imaging Techniques for the Study of Fibrosis in Atrial Fibrillation Ablation: From Molecular Mechanisms to Therapeutical Perspectives
by: Francesco De Sensi, et al.
Published: (2021-05-01)